Late Complications After the Fontan Palliation

The Fontan palliation is a life-saving surgical strategy used for management of children born with single ventricle physiology. Despite early successes in childhood, long- term complications are common in the adult, and occur irrespective of underlying cardiac anatomy or type of Fontan connection created. Ubiquitous abnormalities in hemodynamics can be attributed to chronically elevated systemic venous pressures, decreased cardiac output, or a combination of the two. As Fontan survivorship continues to expand, our understanding of the development of late complications continues to evolve, although much still remains unknown.

The burden of illness is substantial in adulthood and is likely to escalate with increasing numbers of late survivors, with more adults currently living with congenital heart disease as compared with children.1 Nevertheless, survival to the fifth decade of life and beyond, is associated with cautious optimism as the prognosis remains guarded for the older Fontan patient. Specifically, there are data which suggest that life expectancy of a 40 year Fontan survivor, expressed as a standardized mortality ratio, is equivalent to a 75 year old in the general population.2 Pressures within the Fontan circulation are expected to be higher than typical right atrial pressures, will typically rise over time, and are often linked with increased premature morbidity and early mortality.

In recent decades we have witnessed a myriad of cardiovascular complications which have paralleled increased survival, a testament to the limited durability of a Fontan circulation.

Numerous cardiovascular complications have been recognized and may contribute to failing Fontan physiology. These include:

ARRHYTHMIA

Sinus node dysfunction, atrial tachyarrhythmias [such as atrial fibrillation, atrial flutter or intra-atrial re-entry tachycardia], or ventricular tachycardia

VENTRICULAR DYSFUNCTION

Diastolic dysfunction is more common than systolic dysfunction

ATRIOVENTRICULAR VALVE FAILURE

THROMBOEMBOLIC DISEASE

Intracardiac thrombi/pulmonary emboli or stroke

CYANOSIS

Often attributed to structural abnormalities such as veno-venous collaterals, atrerio-venous malformations or persistence of a Fontan fenestration.

Given the relatively recent appreciation of the multisystem nature of Fontan failure, contemporary management of late complications after the Fontan palliation will, by necessity, include extracardiac in addition to intracardiac manifestations of disease. Multidisciplinary expertise will be essential for risk stratification and provision of comprehensive care.

Fontan-associated extracardiac complications may include, but are not limited to, the following organ systems:

1

Liver Disease

Cirrhosis, ascites, portal hypertension, hepatocellular carcinoma

2

Kidney Dysfunction

Reduced eGFR, proteinuria

3

Venous Stasis

Varicose veins, stasis ulcers, edema

4

Protein-Losing Enteropathy/Plastic Bronchitis/Lymphatic Abnormalities

5

Endocrine and Reproductive Issues

6

Brain and Neurocognitive Dysfunction

Therapeutic options for those with a failing Fontan physiology are extremely limited. Medical therapies can only be expected to provide temporary, symptomatic relief. Surgical strategies such as Fontan conversion or heart transplantation are relatively high-risk and are applicable only to a minority of patients. Mechanical support as a therapeutic option remains controversial. Innovative approaches to management will be critical to enhance survival of this vulnerable population. Emerging data are pointing towards potential benefit in lymphatic drainage interventions or external ventilation strategies, although further study is required before these options can be more widely applied in clinical practice.